Health & Medicine

The Museum's collections of medical science artifacts represent nearly all aspects of health and medical practice. Highlights include early X-ray apparatuses, such as one of Wilhelm Roentgen's tubes, penicillin mold from Alexander Fleming’s experiments, and Jonas Salk's original polio vaccine. More recent acquisitions include the first artificial heart implanted in a human, the earliest genetically engineered drugs, and materials related to David, the "Bubble Boy." Other artifacts range from artificial limbs and implant devices to bloodletting and dental instruments, beauty products, and veterinary equipment. The contents of a medieval apothecary shop and an 1890s drugstore form part of the collections, along with patent and alternative medicines. The collections also document the many differing perspectives on health and medical issues, from patients, family members, doctors, nurses, medical students, and out-of-the-mainstream health practitioners.

Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
date made
1988
product expiration date
1988-07
maker
Schering Corporation
ID Number
1987.0781.06
catalog number
1987.0781.06
accession number
1987.0781
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
date made
1988
product expiration date
1988-03
maker
Schering Corporation
ID Number
1987.0781.01
accession number
1987.0781
catalog number
1987.0781.01
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
date made
1988
product expiration date
1988-07
maker
Schering Corporation
ID Number
1987.0781.05
accession number
1987.0781
catalog number
1987.0781.05
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
date made
1988
product expiration date
1988-03
maker
Schering Corporation
ID Number
1987.0781.04
accession number
1987.0781
catalog number
1987.0781.04
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
date made
1988
product expiration date
1988-03
maker
Schering Corporation
ID Number
1987.0781.02
catalog number
1987.0781.02
accession number
1987.0781
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur.
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
date made
1988
product expiration date
1988-03
maker
Schering Corporation
ID Number
1987.0781.03
accession number
1987.0781
catalog number
1987.0781.03
Currently not on view
Location
Currently not on view
date made
ca 1996
product expiration date
1996-08-15
maker
Schering Corporation
ID Number
2019.0108.22
accession number
2019.0108
catalog number
2019.0108.22
The indications or uses for this product as provided by the manufacturer are:LaxativeCurrently not on view
Description
The indications or uses for this product as provided by the manufacturer are:
Laxative
Location
Currently not on view
date made
ca 1932
collection
Reid Drugstore
maker
Schering Corporation
ID Number
1984.0351.019
accession number
1984.0351
catalog number
1984.0351.019

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.